To help you learn more about next-generation sequencing and some of the ways it is being used in cancer research, we’ve compiled the following resources.

You’ll find video tutorials and presentations from researchers about how Illumina sequencing technology, systems, and kits are helping to create breakthroughs in cancer research.
Learn MoreView papers showing how the growing community of Illumina customers, collaborators, and internal scientists are using our products for a wide range of cancer research applications.
Learn MoreIn this section, find out what cancer researchers are discovering with Illumina systems.
Learn More
A new enrichment-based cancer research assay interrogates both DNA and RNA, detecting small variants, gene amplifications, gene fusions. and splice variants.

Kenneth Bloom, MD, FCAP, Chief Medical Officer at Clarient (GE Healthcare) discusses the practical aspects of applying NGS in clinical research.

A new UK program seeking to improve health outcomes of cancer patients and their families will use TruSight Cancer from Illumina.

Molecular profiling that combines DNA- and RNA-level data can more easily identify genes that may be driving cancer.

Deep analysis of exosomal DNA found in the blood of pancreatic cancer subjects offers insight into the potential of liquid biopsies.